-
Two studies have identified a novel inclusion found in a subset of FTLD brains and categorize the clinical entity of the behavioral variant of FTLD, based on anatomical patterns.
-
Fixed dose of IVIg may not be effective in all patients with GBS.
-
Neuropathy occurs with a high frequency in patients with end-stage liver disease, but rarely causes disability.
-
Immunomodulatory therapy reduces the rate of conversion to generalized myasthenia gravis in seniors with pure ocular myasthenia.
-
After 1 year, fewer than half of patients presenting with fatigue will have a diagnosis.
-
-
Losartan 150 mg/day reduced left ventricular ejection fraction, intolerance to ACE inhibitors, and the rate of death and/or hospital admission for heart failure in patients with CHF more than did losartan 50 mg/day, thereby demonstrating the potential value of uptitrating ARB doses to confer clinical benefit.
-
-
The FDA has approved tranexamic acid, an antifibrinolytic drug, for the treatment of cyclic heavy menstrual bleeding.
-
Low-level lead intoxication, known to adversely affect young children's cognitive development and behavior, may also harm young adults.